FDA Advisory committee wants to hear your story: AstraZeneca & Seroquel
Information found on Furious Seasons.
"The FDA psychopharmacology advisory committee is holding hearings on AstraZeneca's applications to have its antipsychotic Seroquel approved by the FDA for one of three depression indications (including long-term maintenance) and anxiety."--Dawdy
How to submit your testimony in person:
Contact Yvette Waples, at (301) 827-6790
(or) by email at Yvette.Waples@fda.hhs.gov (by the close of business on March 18, 2009. )
How to submit written testimony:
Email:Yvette.Waples@fda.hhs.gov
FAX: (301) 827-6778
MAIL:
Yvette Waples
Center for Drug Evaluation and Research (HFD–21),
Food and Drug Administration, 5600 Fishers Lane
(for express delivery, 5630 Fishers Lane, rm. 1093),
Rockville, MD 20857.
------------
My opinion:
ANY adverse event you experienced as a side effect of taking Seroquel should be sent to the committee. Tell your story! I had horrific withdrawals, gained weight, and couldn't operate a vehicle after the drug knocked me out for 14 hours, I could barely function for the brain fog. That wasn't the XR(extended release) version up for approval for depression and anxiety!
Wednesday, March 18, 2009
Subscribe to:
Post Comments (Atom)








0 comments:
Post a Comment